节点文献

食管癌后程加速超分割放疗协同周剂量紫杉醇化疗的疗效分析

Effective analysis of late course accelerated fractionated irradiation combined with concurrent chemotherapy for treating esophageal cancer

  • 推荐 CAJ下载
  • PDF下载
  • 不支持迅雷等下载工具,请取消加速工具后下载。

【作者】 丁柏英马胜禄谢朝辉

【Author】 DING Bo-ying1,MA Sheng-lu2,XIE Chao-hui1(1.Department of Radiotherapy,Chengde Municipal Tumor Hospital,Chengde,Hebei 067000,China;2.Shiji Hospital of Luanping County,Luanping,Hebei 068250,China)

【机构】 承德市肿瘤医院放疗科滦平县世济医院

【摘要】 目的:观察放射治疗配合紫杉醇化疗对食管癌的临床疗效。方法:对173例食管癌病人根据不同的治疗方法分为两组:单纯放射治疗组(单放组)和放射治疗同步化疗组(放化疗组)。单放组80例,采用常规设野放疗,DT 65~70 Gy;放化疗组93例,放疗方法及剂量同单放组,化疗采用紫杉醇每周同步方案。两组均随访2年。结果:局部近期疗效放化疗组好于单放组,两组差异有显著性(P<0.05)。放化疗组与单放组1、2年生存率单放组为51.3%(41/80)、32.5%(26/80),同步放化组为87%(81/93)、68.8%(64/93)。两组差异有显著性(P<0.05)。结论:同步放化疗优于单纯放射治疗,可明显提高食管癌的疗效。

【Abstract】 Objective:To investigate the effect of radiotherapy combined with paclitaxel on esophageal cancer.Methods:173 cases of esophageal cancer were divided into two groups.The simple radiotherapy group(80 cases) received the conventional radiotherapy with a total of 65~70 Gy,and the concurrent radiochemotherapy group(93 cases) was treated by the radiotherapy with the same method and same dosage plus the chemotherapy with weekly paclitaxel.Both groups were followed up for 2 years.Results:The local and short term effect in the radiochemotherapy group was better than that in the simple radiotherapy group with the statistical difference(P<0.05).The 1-year and 2-year survival rates were 51.3%(421/80) and 32.5%(26/80) in the simple radiotherapy group and 76.3%(71/93) and 58.1%(54/93) in the radiochemotherapy group with statistical difference(P<0.05).Conclusion:Concurrent radiochemotherapy is superior to simple radiotherapy in treating esophageal cancer,which increases the curative effect.

【基金】 承德市科研指导计划项目(200621040)
  • 【文献出处】 现代医药卫生 ,Modern Medicine & Health , 编辑部邮箱 ,2011年01期
  • 【分类号】R735.1
  • 【下载频次】50
节点文献中: 

本文链接的文献网络图示:

本文的引文网络